Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

A J Thompson; D Miller; B Youl; D MacManus; S Moore; D Kingsley; B Kendall; A Feinstein; W I McDonald

doi:10.1212/wnl.42.1.60

Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

Neurology. 1992 Jan;42(1):60-3. doi: 10.1212/wnl.42.1.60.

Authors

A J Thompson¹, D Miller, B Youl, D MacManus, S Moore, D Kingsley, B Kendall, A Feinstein, W I McDonald

Affiliation

¹ NMR Research Group, Institute of Neurology, Queen Square, London, England.

PMID: 1734325
DOI: 10.1212/wnl.42.1.60

Abstract

In the planning of MRI protocols to monitor disease activity in multiple sclerosis (MS), the clinical subtype needs to be considered. In this serial gadolinium-enhanced MRI study, we demonstrated differences between patients with early relapsing/remitting MS and benign MS in both the production of new lesions and the occurrence of enhancement.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Contrast Media
Gadolinium DTPA
Humans
Image Enhancement*
Magnetic Resonance Imaging*
Middle Aged
Multiple Sclerosis / diagnosis*
Multiple Sclerosis / physiopathology
Organometallic Compounds*
Pentetic Acid*
Recurrence
Time Factors

Substances

Contrast Media
Organometallic Compounds
Pentetic Acid
Gadolinium DTPA